Research Spotlight

Posted March 15th 2018

Treatment of Freiberg Disease.

Jacob R. Zide M.D.

Jacob R. Zide M.D.

Seybold, J. D. and J. R. Zide (2018). “Treatment of Freiberg Disease.” Foot Ankle Clin 23(1): 157-169.

Full text of this article.

Freiberg disease, or osteochondrosis of the lesser metatarsal head, usually involves the second metatarsal and presents during the second or third decades of life. Conservative measures to relieve pressure on the affected metatarsal head are the first-line treatments, with good success for Smillie stage I to III disease. Operative treatments are divided into joint-preserving and joint-reconstructing procedures. Although multiple case series describe success with numerous techniques, there are no established guidelines for treatment. All surgical techniques carry a risk of a stiff or floating toe and transfer metatarsalgia. This article reviews the current surgical treatment options for Freiberg disease.


Posted March 15th 2018

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Manjusha Gaglani M.D.

Manjusha Gaglani M.D.

Russell, K., J. R. Chung, A. S. Monto, E. T. Martin, E. A. Belongia, H. Q. McLean, M. Gaglani, K. Murthy, R. K. Zimmerman, M. P. Nowalk, M. L. Jackson, L. A. Jackson and B. Flannery (2018). “Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.” Vaccine 36(10): 1272-1278.

Full text of this article.

BACKGROUND: There have been inconsistent reports of decreased vaccine effectiveness (VE) against influenza viruses among older adults (aged>/=65years) compared with younger adults in the United States. A direct comparison of VE over multiple seasons is needed to assess the consistency of these observations. METHODS: We performed a pooled analysis of VE over 5 seasons among adults aged>/=18years who were systematically enrolled in the U.S. Flu VE Network. Outpatients with medically-attended acute respiratory illness (cough with illness onset/=75, and>/=65years) to adults aged 18-49years by influenza type and subtype using interaction terms to test for statistical significance and stratified by prior season vaccination status. RESULTS: Analysis included 20,022 adults aged>/=18years enrolled during the 2011-12 through 2015-16 influenza seasons; 4,785 (24%) tested positive for influenza. VE among patients aged>/=65years was not significantly lower than VE among patients aged 18-49years against any subtype with no significant interaction of age and vaccination. VE against A(H3N2) viruses was 14% (95% confidence interval [CI] -14% to 36%) for adults>/=65years and 21% (CI 9-32%) for adults 18-49years. VE against A(H1N1)pdm09 was 49% (95% CI 22-66%) for adults>/=65years and 48% (95% CI 41-54%) for adults 18-49years and against B viruses was 62% (95% CI 44-74%) for adults>/=65years and 55% (95% CI 45-63%) for adults 18-49years. There was no significant interaction of age and vaccination for separate strata of prior vaccination status. CONCLUSIONS: Over 5 seasons, influenza vaccination provided similar levels of protection among older and younger adults, with lower levels of protection against influenza A(H3N2) in all ages.


Posted March 15th 2018

Circulating Dkk1 and TRAIL are Associated with Cognitive Decline in Community-Dwelling, Older Adults with Cognitive Concerns.

Teodoro Bottiglieri Ph.D.

Teodoro Bottiglieri Ph.D.

Ross, R. D., R. C. Shah, S. Leurgans, T. Bottligieri, R. S. Wilson and D. R. Sumner (2018). “Circulating Dkk1 and TRAIL are Associated with Cognitive Decline in Community-Dwelling, Older Adults with Cognitive Concerns.” J Gerontol A Biol Sci Med Sci. Feb 8. [Epub ahead of print].

Full text of this article.

Background: Osteoporosis and Alzheimer’s disease (AD) are common diseases of aging that would seem to be unrelated, but may be linked through the influence of bone-derived signals on brain function. The current study aimed to investigate the relationship between circulating levels of bone-related biomarkers and cognition. Methods: The population included 103 community-dwelling older individuals with memory concerns but without cognitive impairment. A global cognition summary measure was collected at baseline and 6, 12, and 18-months post-enrollment by converting raw scores from 19 cognitive function tests to z-scores and averaging. Baseline plasma concentrations of bone-related biomarkers, including undercarboxylated, carboxylated, and total osteocalcin, parathyroid hormone (PTH), C-terminal telopeptide of collagen 1 (CTX-1), procollagen type 1 amino-terminal propeptide (PINP), osteoprotegrin (OPG), osteopontin (OPN), Dickkopf WNT signaling pathway inhibitor 1 (Dkk1), sclerostin, and amyloid beta peptides (Abeta40 and Abeta42) were measured. Results: Using sex, age, and education-adjusted mixed-effects models, we found that baseline levels of TRAIL (p<0.001), Dkk1 (p=0.014), and CTX-1 (p=0.046) were related to the annual rate of change of global cognition over the 18-month follow-up. In cognitive domain-specific analysis, baseline TRAIL was found to be positively related to the annual rate of change in episodic (p<0.001) and working memory (p=0.016) and baseline Dkk1 was positively related to semantic memory (p=0.027) and negatively related to working memory (p=0.016). Conclusions: These results further confirm the link between bone and brain health and suggest that circulating levels of bone-related biomarkers may have diagnostic potential to predict worsening cognition.


Posted March 15th 2018

Cardiac rupture during acute myocardial infarction diagnosed clinically.

William C. Roberts M.D.

William C. Roberts M.D.

Roberts, W. C. (2018). “Cardiac rupture during acute myocardial infarction diagnosed clinically.” Coron Artery Dis 29(2): 95-96.

Full text of this article.

Rencuzogullari et al. from Kars, Izmir, and Istanbul, Turkey, compared clinical observations in 33 patients with cardiac rupture during acute myocardial infarction (AMI) to observations in 1630 patients, also with AMI but without clinical evidence of cardiac rupture. Compared with the patients without cardiac rupture, those with rupture had a greater percent in Kilip classes II–IV: higher leukocyte counts, higher levels of C-reactive protein, creatinine kinase MB, and peak troponin I; higher frequencies of the thrombus in the left anterior descending coronary artery, higher basal syntax scores, and syntax II percutaneous coronary intervention scores. The systolic blood pressures, glomerular filtration rates, left ventricular ejection fractions, and hemoglobin values were lower. Many of these relations have not been described previously in patients with AMI and cardiac rupture compared with those with AMI but without cardiac rupture. All patients in their study underwent percutaneous coronary intervention, a procedure that may have effects on some of these factors. What are some potential and real problems with this clinical study? Cardiac rupture during AMI is not easily diagnosed clinically, particularly when the rupture site is the left ventricular free wall, the most common rupture site during AMI. Some cases in this clinical study classified as cardiac rupture probably did not have cardiac rupture, and some cases classified as no cardiac rupture probably did have cardiac rupture. Autopsies were not done in any of their patients or, if so, the results of such studies were not reported. Autopsy or surgery, in actuality, may be the only means of accurately diagnosing cardiac rupture if it involves the left ventricular free wall. A relatively high early survival rate (nearly 50% at 30 days) in their rupture cases also raises some doubt of the accuracy of their diagnosis of rupture during life. The type of cardiac rupture was not specified by these authors, namely whether it involved the left ventricular free wall or ventricular septum or a papillary muscle. The latter two are far less frequent than the former and the former is much more difficult to diagnose clinically than the latter two. It might be useful to compare some findings in autopsy-documented cases of cardiac rupture secondary to AMI to autopsy-documented cases of AMI without cardiac rupture. Table 1 summarizes a number of studies 2–15 performed by me and my colleagues, and Table 2 focuses on factors distinguishing cardiac rupture cases from nonruptured autopsy cases during AMI 2–I15. I suspect that some of the observations of the present authors that are at variance with previous principles learned in patients studied at autopsy with cardiac rupture during AMI are probably related to errors in diagnosis of cardiac rupture. As mentioned, left ventricular free wall rupture is by far the most common site of cardiac rupture during AMI and it is often impossible to get an echocardiogram recorded to search for hemopericardium before the fatality occurs. Nevertheless, the authors made a valiant attempt to diagnose cardiac rupture clinically and to compare numerous variables to their nonrupture cases. Such studies are not easy particularly when the ‘instruments of precision’ are less than ideal when diagnosing cardiac rupture secondary to AMI clinically. (Excerpt from text, p. 95; no abstract available.)


Posted March 15th 2018

Get the Lead off Our Backs!

Chet R. Rees M.D.

Chet R. Rees M.D.

Rees, C. R. and B. W. C. Duncan (2018). “Get the Lead off Our Backs!” Tech Vasc Interv Radiol 21(1): 7-15.

Full text of this article.

Many interventionalists face physical challenges almost daily for years or decades. The burden of assuming awkward positions while carrying extra weight can take its toll on the musculoskeletal system to such an extent that the career is ended or modified to exclude procedural aspects. The proliferation of lighter aprons has unfortunately resulted in reduced protection with poor correlation of protection to labeling due to the inadequacies of testing methods for nonlead materials. The protective quality of the non-leads is not superior to lead-containing composites on a weight basis, and the user no longer knows how well they are protected unless buying aprons containing lead. Various useful methods and shields that may reduce radiation exposure are supported by the floor, ceiling, table, or patient. The suspended personal radiation protection system is a recent development which provides substantially greater radiation protection than conventional lead aprons combined with other shields, while also taking all of the weight off of the operator. It is composed of an expansive and thick (1mm Pb equiv) apron with a large face-shield to protect the neck, head, and eyes, and is suspended overhead to provide motion in the x, y, and z planes. Exposures may also be substantially reduced by leaving the area during acquisition sequences and use of power injectors.